ibudilast has been researched along with Glaucoma, Suspect in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glaucoma is a neurodegenerative disease and the leading cause of irreversible blindness worldwide." | 5.43 | The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling. ( Belforte, N; Cueva Vargas, JL; Di Polo, A, 2016) |
| "Glaucoma is a neurodegenerative disease and the leading cause of irreversible blindness worldwide." | 1.43 | The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling. ( Belforte, N; Cueva Vargas, JL; Di Polo, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cueva Vargas, JL | 1 |
| Belforte, N | 1 |
| Di Polo, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Uncovering Inflammatory Mediators of Glaucoma Pathogenesis After Corneal Transplantation in Aqueous Humor and Tears[NCT04339907] | 200 participants (Anticipated) | Interventional | 2020-05-11 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for ibudilast and Glaucoma, Suspect
| Article | Year |
|---|---|
The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling.
Topics: Animals; Axonal Transport; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Disease Models, Anim | 2016 |